J H Rodman|W R Crom - JoVE Visualize

Showing results (91-100 of 104) with videos related to

Pageof 11

Sort By:

Clinical Pharmacy|November 1, 1987

Disposition of phenytoin in critically ill trauma patientsB A Boucher, J H Rodman, T C Fabian, et al.

Cancer Research|September 15, 1988

Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemiaC H Pui, S S de Graaf, L W Dow, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998

Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretionW C Zamboni, P J Houghton, R K Johnson, et al.

Pharmacotherapy|November 5, 1997

Pharmacokinetics of azithromycin after single- and multiple-doses in childrenR C Stevens, M D Reed, J L Shenep, et al.

American Journal of Surgery|March 1, 1994

Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal traumaT C Fabian, M M Hess, M A Croce, et al.

Leukemia|October 6, 2000

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.

Cancer Chemotherapy and Pharmacology|January 27, 1998

Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.

Journal of the National Cancer Institute|April 6, 1994

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumorsN M Marina, J H Rodman, D J Murry, et al.

Cancer Research|June 15, 1990

Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenograftsJ A Houghton, L G Williams, S S de Graaf, et al.

The New England Journal of Medicine|August 12, 1993

A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.

Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:

Pageof 11

Clinical Pharmacy|November 1, 1987

Disposition of phenytoin in critically ill trauma patientsB A Boucher, J H Rodman, T C Fabian, et al.

Cancer Research|September 15, 1988

Phase I clinical trial of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in vitro drug sensitivity testing in children with refractory leukemiaC H Pui, S S de Graaf, L W Dow, et al.

The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998

Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretionW C Zamboni, P J Houghton, R K Johnson, et al.

Pharmacotherapy|November 5, 1997

Pharmacokinetics of azithromycin after single- and multiple-doses in childrenR C Stevens, M D Reed, J L Shenep, et al.

American Journal of Surgery|March 1, 1994

Superiority of aztreonam/clindamycin compared with gentamicin/clindamycin in patients with penetrating abdominal traumaT C Fabian, M M Hess, M A Croce, et al.

Leukemia|October 6, 2000

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effectsM K Arnaout, K M Radomski, D K Srivastava, et al.

Cancer Chemotherapy and Pharmacology|January 27, 1998

Clinical effects and pharmacokinetics of the fusion protein PIXY321 in children receiving myelosuppressive chemotherapyW L Furman, J H Rodman, M E Tonda, et al.

Journal of the National Cancer Institute|April 6, 1994

Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumorsN M Marina, J H Rodman, D J Murry, et al.

Cancer Research|June 15, 1990

Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenograftsJ A Houghton, L G Williams, S S de Graaf, et al.

The New England Journal of Medicine|August 12, 1993

A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell diseaseJ A Wilimas, P M Flynn, S Harris, et al.

Pageof 11